BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND DROSHA, HSA242976, 29102, RNASEN, ENSG00000113360, Q9NRR4, RNASE3L, RN3, RANSE3L, Etohi2
51 results:

  • 1. Association of drosha rs6877842, rs642321 and rs10719 polymorphisms with increased susceptibility to breast cancer: A case-control study with genotype and haplotype analysis.
    Kamalabad ST; Zamanzadeh Z; Rezaei H; Tabatabaeian M; Abkar M
    Breast Dis; 2023; 42(1):45-58. PubMed ID: 36911928
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer.
    Li Y; Xing Y; Wang X; Hu B; Zhao X; Zhang H; Han F; Geng N; Wang F; Li Y; Li J; Jin F; Li F
    Cell Rep; 2021 Dec; 37(12):110127. PubMed ID: 34936874
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bioinformatic Searching for Optimal RNA Targets of Dimeric Compounds Informs Design of a MicroRNA-27a Inhibitor.
    Benhamou RI; Choudhary S; Lekah E; Tong Y; Disney MD
    ACS Chem Biol; 2022 Jan; 17(1):5-10. PubMed ID: 34898169
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication.
    Sheng X; Dai H; Du Y; Peng J; Sha R; Yang F; Zhou L; Lin Y; Xu S; Wu Y; Yin W; Lu J
    J Exp Clin Cancer Res; 2021 Jun; 40(1):205. PubMed ID: 34162418
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
    Felicio PS; Grasel RS; Campacci N; de Paula AE; Galvão HCR; Torrezan GT; Sabato CS; Fernandes GC; Souza CP; Michelli RD; Andrade CE; Barros BDF; Matsushita MM; Revil T; Ragoussis J; Couch FJ; Hart SN; Reis RM; Melendez ME; Tonin PN; Carraro DM; Palmero EI
    Hum Mutat; 2021 Mar; 42(3):290-299. PubMed ID: 33326660
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Oncogenic AURKA-enhanced N
    Peng F; Xu J; Cui B; Liang Q; Zeng S; He B; Zou H; Li M; Zhao H; Meng Y; Chen J; Liu B; Lv S; Chu P; An F; Wang Z; Huang J; Zhan Y; Liao Y; Lu J; Xu L; Zhang J; Sun Z; Li Z; Wang F; Lam EW; Liu Q
    Cell Res; 2021 Mar; 31(3):345-361. PubMed ID: 32859993
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Novel, abundant drosha isoforms are deficient in miRNA processing in cancer cells.
    Dai L; Hallmark L; Bofill De Ros X; Crouch H; Chen S; Shi T; Yang A; Lian C; Zhao Y; Tran B; Gu S
    RNA Biol; 2020 Nov; 17(11):1603-1612. PubMed ID: 32819190
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A genetic variant in the flanking region of miR-182 could decrease the susceptibility to the breast cancer risk in the iranian population.
    Mansouri M; Peymani M; Mohamadynejad P
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(6):806-817. PubMed ID: 31994428
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation.
    Paulsson JO; Backman S; Wang N; Stenman A; Crona J; Thutkawkorapin J; Ghaderi M; Tham E; Stålberg P; Zedenius J; Juhlin CC
    J Pathol; 2020 Feb; 250(2):183-194. PubMed ID: 31621921
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.
    Khan S; Ayub H; Khan T; Wahid F
    Biochimie; 2019 Dec; 167():12-24. PubMed ID: 31493469
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells.
    Klinge CM; Piell KM; Tooley CS; Rouchka EC
    Sci Rep; 2019 Jul; 9(1):9430. PubMed ID: 31263129
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.
    Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of miRNA biosynthesis genes
    Wen J; Lv Z; Ding H; Fang X; Sun M
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654164
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of components of microRNA machinery in carcinogenesis.
    Kian R; Moradi S; Ghorbian S
    Exp Oncol; 2018 Mar; 40(1):2-9. PubMed ID: 29600985
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Mekala JR; Naushad SM; Ponnusamy L; Arivazhagan G; Sakthiprasad V; Pal-Bhadra M
    Gene; 2018 Jan; 641():248-258. PubMed ID: 29038000
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.
    Antoniali G; Serra F; Lirussi L; Tanaka M; D'Ambrosio C; Zhang S; Radovic S; Dalla E; Ciani Y; Scaloni A; Li M; Piazza S; Tell G
    Nat Commun; 2017 Oct; 8(1):797. PubMed ID: 28986522
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Impaired expression of drosha in breast cancer.
    Poursadegh Zonouzi AA; Shekari M; Nejatizadeh A; Shakerizadeh S; Fardmanesh H; Poursadegh Zonouzi A; Rahmati-Yamchi M; Tozihi M
    Breast Dis; 2017; 37(2):55-62. PubMed ID: 28598829
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic variation and RNA structure regulate microRNA biogenesis.
    Fernandez N; Cordiner RA; Young RS; Hug N; Macias S; Cáceres JF
    Nat Commun; 2017 May; 8():15114. PubMed ID: 28466845
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy.
    Anderson TL; Glazebrook KN; Murphy BL; Viers LD; Hieken TJ
    Eur J Radiol; 2017 Apr; 89():163-168. PubMed ID: 28267534
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Nuclear drosha enhances cell invasion via an EGFR-ERK1/2-MMP7 signaling pathway induced by dysregulated miRNA-622/197 and their targets LAMC2 and CD82 in gastric cancer.
    Xu L; Hou Y; Tu G; Chen Y; Du YE; Zhang H; Wen S; Tang X; Yin J; Lang L; Sun K; Yang G; Tang X; Liu M
    Cell Death Dis; 2017 Mar; 8(3):e2642. PubMed ID: 28252644
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.